More News from Symposium
-
SABCS Snippets: SERENA-4, SERENA-6, and the timing of endocrine therapy
SABCS Co-Director Virginia G. Kaklamani, MD, joins Erika Hamilton, MD, of Sarah Cannon Research Institute, and Komal Jhaveri, MD, of Memorial Sloan Kettering Cancer Center to discuss when endocrine therapy should change in HR-positive metastatic breast cancer and what evidence should guide that decision.
-
Registration now open for SABCS 2026
The global breast cancer community returns to San Antonio this December for four days of groundbreaking research and scientific discovery. Now in its 49th year, SABCS spans the full spectrum of breast cancer research, from etiology, prevention, and diagnosis to treatment and survivorship. Join us December 8–11 in San Antonio. Register today for SABCS 2026.
-
Share high-impact research with the breast cancer community
The San Antonio Breast Cancer Symposium is welcoming late-breaking abstract submissions now through Wednesday, September 30, at 11:59 p.m. CT.